SUNPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 1 970.9 INR 1.54% Market Closed

Market Cap: ₹4.7T

	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	IN
	Deutsche Lufthansa AG MIL:LHA	DE
	Ross Stores Inc NASDAQ:ROST	US
O	Orient Overseas (International) Ltd OTC:OROVF	HK
	Energy Resources Of Australia Ltd ASX:ERA	AU
J	J Sainsbury PLC XMUN:SUY1	UK
	VGP NV XBRU:VGP	BE
G	Genmab A/S DUS:GE9	DK
C	China Reinsurance Group Corp F:C53	CN
F	Flowserve Corp XMUN:FWV	US
	Hokuriku Electric Power Co OTC:HOKRF	JP
	Dentsu Group Inc F:DEN0	JP
S	Screen Holdings Co Ltd SWB:DAO	JP
	Telekom Malaysia Bhd OTC:MYTEF	MY
E	Energy Resources Of Australia Ltd XMUN:EJ7	AU
G	George Weston Ltd F:WX5	CA

Profitability Summary

Sun Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 80%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

22% > 24%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

19% > 19%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

8% > 16%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC